SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Piramal Healthcare to present Phase I clinical data for oral anticancer molecule

22 May 2012 Evaluate

Piramal Healthcare will present its Phase I clinical trial data for its investigational new drug candidate P1446A-05 at the Annual Meeting of the American Society for Clinical Oncology (ASCO) being convened in Chicago from June 1-5, 2012. This year’s ASCO meeting will bring together more than 34,000 participants from around the world and will focus on the theme of collaborating to Conquer Cancer.

The two posters from Piramal Healthcare and participating investigators to be discussed on June 2, 2012, in the Developmental Therapeutics- Expiremental Therapeutics session, will report results of Phase I Clinical studies for P1446A-05 conducted in India and Canada, each investigating two different closing schedules.

P1446A-05 is a potent inhibitor of cyclin dependent kinases (Cdks) which are enzymes that regulate the cell cycle. Dysregulation of the cell cycle is often observed in human malignancies which derive malignant growth and unbalances the normal balance between cell division and death.

P1446A-05 will be the second molecule in Piramal’s oncology pipeline to enter Phase II trials. The first molecule P276 is in Phase II/III trials for multiple indications of cancer.

Piramal Ent - Amalga Share Price

1124.60 0.00 (0.00%)
22-Sep-2025 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×